The pathophysiology of Type 2 diabetes (T2DM) is characterized by a low-grade chronic inflammation, with the release of inflammatory cytokines by innate immune cells (mainly macrophages and dendritic cells) that impair insulin action [1]. Here, INS is linked to type 2 diabetes mellitus.